Benzinga · Mar 5, 2026
Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1
Canaccord Genuity analyst Kyle Mikson maintains Quantum-Si (NASDAQ:QSI) with a Hold and lowers the price target from $1.5 to $1.
QS
NASDAQ · QSI
Quantum-Si incorporated
Healthcare · Biotechnology
$0.73
Up+$0.05 (+7.44%)
Updated Sep 17, 2026, 2:10 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 272.8M
- P/E ratio
- -2.41
- Dividend yield
- 0.00%
- 52-week range
- $0.69 – $1.30
- Volume
- 915.22K
- Avg. volume
- 11.82M
Price performance
QSI price history
1M range · 20 trading sessions · Daily adjusted prices
QSI closed at $0.73 after 20 trading sessions, down 5.19% for the selected period.
- Last close
- $0.73
- Period change
- -5.19%
- Period low
- $0.72
- Period high
- $0.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.721 | $0.7532 | $0.721 | $0.7301 | 915.22K |
| Sep 15, 2026 | $0.72 | $0.7409 | $0.72 | $0.72 | 1.17M |
| Sep 14, 2026 | $0.7287 | $0.7478 | $0.7201 | $0.725 | 1.39M |
| Sep 11, 2026 | $0.7391 | $0.755 | $0.7391 | $0.74 | 1.07M |
| Sep 10, 2026 | $0.75 | $0.755 | $0.7251 | $0.7391 | 1.72M |
| Sep 9, 2026 | $0.7602 | $0.7748 | $0.746 | $0.75 | 1.45M |
| Sep 8, 2026 | $0.7672 | $0.79 | $0.76 | $0.76 | 1.05M |
| Sep 4, 2026 | $0.76 | $0.7742 | $0.76 | $0.766 | 898.78K |
| Sep 3, 2026 | $0.7669 | $0.7862 | $0.76 | $0.761 | 980K |
| Sep 2, 2026 | $0.7586 | $0.785 | $0.75 | $0.761 | 1.62M |
| Sep 1, 2026 | $0.75 | $0.7768 | $0.7499 | $0.7573 | 1.5M |
| Aug 31, 2026 | $0.7787 | $0.78 | $0.763 | $0.7659 | 1.13M |
| Aug 28, 2026 | $0.8219 | $0.822 | $0.77 | $0.78 | 2.42M |
| Aug 27, 2026 | $0.7911 | $0.8337 | $0.79 | $0.8031 | 1.38M |
| Aug 26, 2026 | $0.85 | $0.855 | $0.7901 | $0.7906 | 2.66M |
| Aug 25, 2026 | $0.7888 | $0.859 | $0.7817 | $0.8473 | 4.37M |
| Aug 24, 2026 | $0.80 | $0.83 | $0.7515 | $0.7693 | 3.85M |
| Aug 21, 2026 | $0.7848 | $0.931 | $0.78 | $0.835 | 7.83M |
| Aug 20, 2026 | $0.7666 | $0.8099 | $0.7666 | $0.78 | 3.23M |
| Aug 19, 2026 | $0.7193 | $0.7845 | $0.7193 | $0.7701 | 2.86M |
Latest QSI news
The latest Smart Investors Daily articles mentioning QSI.
Stock researchCompany · Overview
QSI research
Overview
Company profile and research snapshot.
Company profile
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 5, 2026 | Canaccord Genuity | Hold | — |
| Dec 22, 2025 | Canaccord Genuity | Hold | — |
| Oct 27, 2025 | Canaccord Genuity | Hold | — |
| Sep 9, 2025 | Canaccord Genuity | Hold | — |
| May 19, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
ChartMill · Mar 3, 2026
Quantum-Si (NASDAQ:QSI) Reports Q4 2025 Revenue Miss, Guides for Strategic Transition Year
Quantum-Si reports Q4 revenue miss, lowers 2026 outlook to focus on launching its next-generation Proteus protein analysis platform.
Benzinga · Mar 3, 2026
Quantum-Si Shares Slip After Q4 Revenue Miss
Here's a look at why Quantum-Si stock is slipping after Q4 earnings.
Benzinga · Mar 3, 2026
Quantum-Si Sees FY2026 Sales $1.000M vs $7.148M Est
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
